1

Meissner Presents New Way to Characterize Ultrafiltration Membranes

Watch Thomas Lazzara Present on SepraPor at BPI Boston 2023

Watch our presentation at the Biotech Week Boston 2023 conference on “An Improved Method of Characterization of Ultrafiltration (UF) Membranes for Bioprocessing”, given by Thomas D. Lazzara, Ph.D., Director of Research and Development. The characterization of ultrafiltration membranes with molecular weight (Mw) markers is a standard method to determine the retention rating of membranes in

Technical Theater Presentations at INTERPHEX New York 2023

INTERPHEX 2023 Tech Update - CryoVault® and SepraPor®

The CryoVault^® Bench Top Freezer was introduced by Meissner’s David Lange, Senior Product Engineer Project Manager. Jessica McRoskey, R&D Process Development Engineer at Meissner, introduced the SepraPor^® ultrafiltration hollow fiber portfolio and outlined how Meissner’s unique membrane characterization process enhances the consistent performance of our hollow fiber filters for both microfiltration and ultrafiltration applications.

More CryoVault^® Information

More SepraPor^® Information

Meissner Filtration Products Has Shortened Its Name to Meissner

It’s official – Meissner has shortened its name to align more closely with the agile, responsive organization that our clients have come to rely on for providing more than critical filtration solutions. For the last 40 years, Meissner has expanded its expertise in the pharma and biotech industries beyond filtration into single-use systems, automatic aseptic filling systems, freeze and thaw platforms for critical biopharmaceuticals, and laboratory and technical services.

The Meissner name and logo have been streamlined just like our timelines from receipt of order to delivery of critical manufacturing solutions.

Meissner will continue to manufacture the same high-quality products, while delivering the same level of expertise, service, and responsiveness that our clients depend on. The Meissner logo has been updated, too, to reflect this name change, and over time, our product labels, packaging, and documentation will also be updated to better align with how industry already refers to us, as Meissner.

Download the Press Release.

New Meissner Facility in Athens GA

Download PDF

Meissner Name Change

Download PDF

Meissner Announces Location of Future Manufacturing Site in Athens, Georgia!

New Manufacturing Location Announced! Athens, Georgia.

Meissner Corporation, a leading manufacturer of advanced microfiltration and single-use systems for production of pharmaceutical drugs, biologics, and cell and gene therapies, will invest nearly $250 million in a new manufacturing facility in Athens, Georgia. The project is expected to create over 1,700 new jobs over the next eight years. Meissner’s new facility will include state-of-the-art cleanroom facilities and laboratories, as well as R&D, and office spaces. Meissner expects to begin operations in early 2026 and will be hiring for a broad range of roles. Interested parties can visit the employment listings on www.meissner.com. The Athens, GA location provides direct access to work with schools such as the University of Georgia, Georgia Institute of Technology, and Athens Technical College for internship and collaboration opportunities through relevant programs of study. The project was supported by the Georgia Department of Economic Development, Invest Athens, Georgia Power, and Georgia Quick Start.

Take a drone tour.

Download the Press Release.

New Meissner Facility in Athens GA

Download PDF

Meissner Name Change

Download PDF

Biotech Week Boston/BPI Virtual Event 2020 Interview – “What’s New at Meissner?”

The BPI US virtual event will run September 21-24, 2020. In this video snippet, Rizwan Chaudhrey, Biotech Blogger, catches up with Karisa Koenig, Director of Marketing, during the event to discuss the opening of Meissner’s Castlebar, Ireland, manufacturing site, the launch of M-Flex^® TPE tubing as a direct replacement option in single-use systems for the C-Flex^® 374 shortage, and the award-winning CryoVault^® freeze/thaw platform for bulk drug substance. Meissner’s Live Lab presentation, delivered by Tristan Winneker, Product Manager, officially launched their portfolio of Seprapor^® hollow fiber filters during the show. The presentation can be viewed On-Demand through the Live Labs section on the virtual portal. A free Exhibit Pass to the event can be requested by visiting https://bit.ly/2FIrLvN. Meissner will be hosting a Solutions Provider booth where visitors can video chat with our team and download product information.

Single-Use Roundtable Discussion is Featured in American Pharmaceutical Review Magazine

A Roundtable panel fielded a series of questions centering on whether single-use technologies had finally become “standard” for biopharmaceutical manufacturing, and if there were unforeseen benefits/disadvantages to the adoption of this technology. Max Blomberg, Executive Director of Operations, participated on behalf of Meissner, along with representatives from companies like Catalent, Advantapure, BioPlan Associates, Pharmatech Associates, and Sartorius.